RMD

NYSE

RESMED INC

Health Care, Health Care Equipment

$211.94

close 7 Aug 2026

-25.46%

52-week change

$30.74B

market cap

$180.27

$293.81

52-week range

Valuation

Market cap$30.74B

P/E (TTM / 5y avg)20.44x36.61x

Forward P/E (FY2027 / FY2028)17.53x16.08x

PEG (TTM / fwd)0.951.95

P/S (TTM)5.55x

P/B4.74x

EV/EBITDA (TTM)14.08x

FCF yield (TTM)5.71%

Cash flow & dividend

FCF (TTM)$1.75B

FCF per share (TTM)$12.09

FCF margin (TTM)31.68%

Dividend yield (indicated / 5y avg)1.13%0.90%

Annualized dividend$2.40

Payout ratio (EPS / FCF)22.39%19.39%

Growth & quality

Revenue YoY, latest Q+10.81%

Diluted EPS YoY, latest Q+10.48%

Operating margin (TTM)34.18%

Net margin (TTM)27.44%

ROE (latest FY)23.47%

Net debt / EBITDA (TTM)-0.47

Interest coverage (TTM)—

Price

-22.96%-5.10%/yrover 5y

Weekly closes · split-adjusted

close 7 Aug 2026

Fundamentals

Fiscal years, last 10, CAGR chips on growth series, plus a dimmed trailing-twelve-month bar

Revenue

5Y CAGR +11.72%10Y CAGR +11.85%

Diluted EPS

5Y CAGR +17.37%10Y CAGR +14.43%

FCF per share

5Y CAGR +18.37%10Y CAGR +17.52%

Operating cash flow

5Y CAGR +16.90%10Y CAGR +16.41%

Free cash flow

5Y CAGR +18.64%10Y CAGR +17.88%

Dividends per share

5Y CAGR +6.42%10Y CAGR +6.73%

Payout ratio

FCF payout ratio

Operating margin

FCF margin

Return on equity

Return on capital employed

Shares outstanding

5Y CAGR +0.21%10Y CAGR +0.41%

Net debt / EBITDA

Interest coverage

Earnings

Street estimates, not SEC filings

Next / Q1 FY27

Date28 Oct 2026

EPS estimate$2.89

Revenue estimate$1.45B

Last reported

Date—

EPS——

Revenue——